{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:42:05Z","timestamp":1792093325373,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A04J0105"],"award-info":[{"award-number":["2023A04J0105"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32500786"],"award-info":[{"award-number":["32500786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82572540"],"award-info":[{"award-number":["82572540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Project of Guangzhou National Laboratory","award":["GZNL2024A01017"],"award-info":[{"award-number":["GZNL2024A01017"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515020068"],"award-info":[{"award-number":["2024B1515020068"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04738-y","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:40:31Z","timestamp":1782495631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rational design of an optimized ferritin nanoparticle vaccine targeting both SARS-CoV-2 and MERS-CoV"],"prefix":"10.1186","volume":"24","author":[{"given":"Yaoming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyue","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4221","authenticated-orcid":false,"given":"Xiancai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"4738_CR1","doi-asserted-by":"crossref","unstructured":"Liu DX, Liang JQ, Fung TS. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae). In Encyclopedia of Virology (Fourth Edition). Edited by Bamford DH, Zuckerman M. Oxford: Academic Press; 2021:428\u2013440.","DOI":"10.1016\/B978-0-12-809633-8.21501-X"},{"key":"4738_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(03)13410-1","volume":"361","author":"CA Donnelly","year":"2003","unstructured":"Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho L-M, Thach T-Q, Chau P, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761\u20136.","journal-title":"Lancet"},{"key":"4738_CR3","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S1473-3099(18)30127-0","volume":"18","author":"DS Hui","year":"2018","unstructured":"Hui DS, Azhar EI, Kim Y-J, Memish ZA, Oh M-d, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217\u201327.","journal-title":"Lancet Infect Dis"},{"key":"4738_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727\u201333.","journal-title":"N Engl J Med"},{"key":"4738_CR5","doi-asserted-by":"crossref","unstructured":"Liu S, Hu M, Liu X, Liu X, Chen T, Zhu Y, Liang T, Xiao S, Li P, Ma X. Nanoparticles and Antiviral Vaccines. In Vaccines. 2024;12.","DOI":"10.3390\/vaccines12010030"},{"key":"4738_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S. The spike protein of SARS-CoV \u2014 a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7:226\u201336.","journal-title":"Nat Rev Microbiol"},{"key":"4738_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/14760584.2018.1506702","volume":"17","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Jiang S, Du L. Prospects for a MERS-CoV spike vaccine. Expert Rev Vaccines. 2018;17:677\u201386.","journal-title":"Expert Rev Vaccines"},{"key":"4738_CR8","doi-asserted-by":"publisher","unstructured":"Min L, Sun Q. Antibodies and Vaccines Target RBD of SARS-CoV-2. Front Mol Biosci. 2021;8:671633. https:\/\/doi.org\/10.3389\/fmolb.2021.671633.","DOI":"10.3389\/fmolb.2021.671633"},{"key":"4738_CR9","doi-asserted-by":"crossref","unstructured":"Mubarak A, Alturaiki W, Hemida MG. Middle east respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development. Journal of Immunology Research 2019, 2019:6491738.","DOI":"10.1155\/2019\/6491738"},{"key":"4738_CR10","doi-asserted-by":"crossref","unstructured":"Xia X. Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design. In Viruses. 2021;13.","DOI":"10.3390\/v13010109"},{"key":"4738_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.chom.2022.04.014","volume":"30","author":"JP Evans","year":"2022","unstructured":"Evans JP, Zeng C, Qu P, Faraone J, Zheng Y-M, Carlin C, Bednash JS, Zhou T, Lozanski G, Mallampalli R, et al. Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2. Cell Host Microbe. 2022;30:1093\u2013e11021093.","journal-title":"Cell Host Microbe"},{"key":"4738_CR12","doi-asserted-by":"publisher","unstructured":"Tai W, Wang Y, Fett Craig A, Zhao G, Li F, Perlman S, Jiang S, Zhou Y, Du L. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. J Virol. 2016;91. https:\/\/doi.org\/10.1128\/jvi.01651-01616.","DOI":"10.1128\/jvi.01651-01616"},{"key":"4738_CR13","doi-asserted-by":"publisher","first-page":"e00376","DOI":"10.1128\/jvi.00376-24","volume":"98","author":"G Wang","year":"2024","unstructured":"Wang G, Verma Abhishek K, Guan X, Bu F, Odle Abby E, Li F, Liu B, Perlman S, Du L. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. J Virol. 2024;98:e00376\u201300324.","journal-title":"J Virol"},{"key":"4738_CR14","doi-asserted-by":"crossref","unstructured":"Guan X, Verma AK, Liu Q, Palacios M, Odle AE, Perlman S, Du L. Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV. In Vaccines, vol. 13; 2025.","DOI":"10.3390\/vaccines13030293"},{"key":"4738_CR15","doi-asserted-by":"crossref","unstructured":"Lee DB, Kim H, Jeong JH, Jang US, Jang Y, Roh S, Jeon H, Kim EJ, Han SY, Maeng JY et al. Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge. Proceedings of the National Academy of Sciences 2023, 120:e2208425120.","DOI":"10.1073\/pnas.2208425120"},{"key":"4738_CR16","doi-asserted-by":"publisher","first-page":"2303366","DOI":"10.1002\/advs.202303366","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Sun J, Zheng J, Li S, Rao H, Dai J, Zhang Z, Wang Y, Liu D, Chen Z, et al. Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models. Adv Sci. 2024;11:2303366.","journal-title":"Adv Sci"},{"key":"4738_CR17","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.csbj.2021.04.061","volume":"19","author":"A Nagy","year":"2021","unstructured":"Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. 2021;19:2508\u201317.","journal-title":"Comput Struct Biotechnol J"},{"key":"4738_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","volume":"12","author":"J-H Tian","year":"2021","unstructured":"Tian J-H, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, et al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun. 2021;12:372.","journal-title":"Nat Commun"},{"key":"4738_CR19","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma X, Zou F, Yu F, Li R, Yuan Y, Zhang Y, Zhang X, Deng J, Chen T, Song Z, et al. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses. Immunity. 2020;53:1315\u2013e13301319.","journal-title":"Immunity"},{"key":"4738_CR20","doi-asserted-by":"publisher","first-page":"e1009897","DOI":"10.1371\/journal.ppat.1009897","volume":"17","author":"Q Geng","year":"2021","unstructured":"Geng Q, Tai W, Baxter VK, Shi J, Wan Y, Zhang X, Montgomery SA, Taft-Benz SA, Anderson EJ, Knight AC, et al. Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection. PLoS Pathog. 2021;17:e1009897.","journal-title":"PLoS Pathog"},{"key":"4738_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen AA, Gnanapragasam PNP, Lee YE, Hoffman PR, Ou S, Kakutani LM, Keeffe JR, Wu H-J, Howarth M, West AP, et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science. 2021;371:735\u201341.","journal-title":"Science"},{"key":"4738_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls AC, Fiala B, Sch\u00e4fer A, Wrenn S, Pham MN, Murphy M, Tse LV, Shehata L, O\u2019Connor MA, Chen C, et al. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell. 2020;183:1367\u2013e13821317.","journal-title":"Cell"},{"key":"4738_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41591-021-01370-1","volume":"27","author":"BJ Ward","year":"2021","unstructured":"Ward BJ, Gobeil P, S\u00e9guin A, Atkins J, Boulay I, Charbonneau P-Y, Couture M, D\u2019Aoust M-A, Dhaliwall J, Finkle C, et al. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med. 2021;27:1071\u20138.","journal-title":"Nat Med"},{"key":"4738_CR24","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/j.vaccine.2021.07.034","volume":"39","author":"A-C Fluckiger","year":"2021","unstructured":"Fluckiger A-C, Ontsouka B, Bozic J, Diress A, Ahmed T, Berthoud T, Tran A, Duque D, Liao M, McCluskie M, et al. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity. Vaccine. 2021;39:4988\u20135001.","journal-title":"Vaccine"},{"key":"4738_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo M, Wei C-J, Yassine HM, McTamney PM, Boyington JC, Whittle JRR, Rao SS, Kong W-P, Wang L, Nabel GJ. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102\u20136.","journal-title":"Nature"},{"key":"4738_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine J, Julien J-P, Menis S, Ota T, Kalyuzhniy O, McGuire A, Sok D, Huang P-S, MacPherson S, Jones M, et al. Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors. Science. 2013;340:711\u20136.","journal-title":"Science"},{"key":"4738_CR27","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun TUJ, Andersson A-MC, Draper SJ, Howarth M. Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination. ACS Nano. 2018;12:8855\u201366.","journal-title":"ACS Nano"},{"key":"4738_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","volume":"592","author":"S Boyoglu-Barnum","year":"2021","unstructured":"Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park Y-J, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature. 2021;592:623\u20138.","journal-title":"Nature"},{"key":"4738_CR29","doi-asserted-by":"publisher","first-page":"115036","DOI":"10.1016\/j.celrep.2024.115036","volume":"43","author":"CW Chao","year":"2024","unstructured":"Chao CW, Sprouse KR, Miranda MC, Catanzaro NJ, Hubbard ML, Addetia A, Stewart C, Brown JT, Dosey A, Valdez A, et al. Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV. Cell Rep. 2024;43:115036.","journal-title":"Cell Rep"},{"key":"4738_CR30","doi-asserted-by":"publisher","first-page":"eabq0839","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen AA, van Doremalen N, Greaney AJ, Andersen H, Sharma A, Starr TN, Keeffe JR, Fan C, Schulz JE, Gnanapragasam PNP, et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science. 2022;377:eabq0839.","journal-title":"Science"},{"key":"4738_CR31","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41423-021-00641-8","volume":"18","author":"R Li","year":"2021","unstructured":"Li R, Ma X, Deng J, Chen Q, Liu W, Peng Z, Qiao Y, Lin Y, He X, Zhang H. Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques. Cell Mol Immunol. 2021;18:1058\u201360.","journal-title":"Cell Mol Immunol"},{"key":"4738_CR32","doi-asserted-by":"crossref","unstructured":"Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proceedings of the National Academy of Sciences 2012, 109:E690-E697.","DOI":"10.1073\/pnas.1115485109"},{"key":"4738_CR33","doi-asserted-by":"publisher","first-page":"26523","DOI":"10.1073\/pnas.1909653116","volume":"116","author":"AH Keeble","year":"2019","unstructured":"Keeble AH, Turkki P, Stokes S, Khairil Anuar INA, Rahikainen R, Hyt\u00f6nen VP, Howarth M. Approaching infinite affinity through engineering of peptide\u2013protein interaction. Proc Natl Acad Sci. 2019;116:26523\u201333.","journal-title":"Proc Natl Acad Sci"},{"key":"4738_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14:290\u20136.","journal-title":"Nat Methods"},{"key":"4738_CR35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"4738_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr Sect D. 2010;66:486\u2013501.","journal-title":"Acta Crystallogr Sect D"},{"key":"4738_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr Sect D. 2010;66:213\u201321.","journal-title":"Acta Crystallogr Sect D"},{"key":"4738_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70\u201382.","journal-title":"Protein Sci"},{"key":"4738_CR39","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/pharmaceutics13101621","volume":"13","author":"MQ Rodrigues","year":"2021","unstructured":"Rodrigues MQ, Alves PM, Rold\u00e3o A. Functionalizing Ferritin Nanoparticles for Vaccine Development. Pharmaceutics. 2021;13:1621.","journal-title":"Pharmaceutics"},{"key":"4738_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/acsbiomedchemau.2c00003","volume":"2","author":"A Mohanty","year":"2022","unstructured":"Mohanty A, Parida A, Raut RK, Behera RK. Ferritin: A Promising Nanoreactor and Nanocarrier for Bionanotechnology. ACS Bio Med Chem Au. 2022;2:258\u201381.","journal-title":"ACS Bio Med Chem Au"},{"key":"4738_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jmb.2009.04.078","volume":"390","author":"KJ Cho","year":"2009","unstructured":"Cho KJ, Shin HJ, Lee J-H, Kim K-J, Park SS, Lee Y, Lee C, Park SS, Kim KH. The Crystal Structure of Ferritin from Helicobacter pylori Reveals Unusual Conformational Changes for Iron Uptake. J Mol Biol. 2009;390:83\u201398.","journal-title":"J Mol Biol"},{"key":"4738_CR42","doi-asserted-by":"publisher","first-page":"101535","DOI":"10.1016\/j.apmt.2022.101535","volume":"28","author":"K Krausova","year":"2022","unstructured":"Krausova K, Charousova M, Kratochvil Z, Takacsova P, Tesarova B, Sivak L, Peskova MK, Sukupova M, Zivotska H, Makovicky P, et al. Toward understanding the kinetics of disassembly of ferritins of varying origin and subunit composition. Appl Mater Today. 2022;28:101535.","journal-title":"Appl Mater Today"},{"key":"4738_CR43","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K, et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 2020;369:1010\u20134.","journal-title":"Science"},{"key":"4738_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty S. T Follicular Helper Cell Differentiation, Function, and Roles in Disease. Immunity. 2014;41:529\u201342.","journal-title":"Immunity"},{"key":"4738_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.abd3871","volume":"370","author":"J Mateus","year":"2020","unstructured":"Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, Burger ZC, Rawlings SA, Smith DM, Phillips E, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89\u201394.","journal-title":"Science"},{"key":"4738_CR46","doi-asserted-by":"publisher","first-page":"eaan5393","DOI":"10.1126\/sciimmunol.aan5393","volume":"2","author":"J Zhao","year":"2017","unstructured":"Zhao J, Alshukairi AN, Baharoon SA, Ahmed WA, Bokhari AA, Nehdi AM, Layqah LA, Alghamdi MG, Al Gethamy MM, Dada AM, et al. Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses. Sci Immunol. 2017;2:eaan5393.","journal-title":"Sci Immunol"},{"key":"4738_CR47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.aav9033","volume":"365","author":"MC Crank","year":"2019","unstructured":"Crank MC, Ruckwardt TJ, Chen M, Morabito KM, Phung E, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Gordon IJ, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505\u20139.","journal-title":"Science"},{"key":"4738_CR48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","volume":"20","author":"JL Slon-Campos","year":"2019","unstructured":"Slon-Campos JL, Dejnirattisai W, Jagger BW, L\u00f3pez-Camacho C, Wongwiwat W, Durnell LA, Winkler ES, Chen RE, Reyes-Sandoval A, Rey FA, et al. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection. Nat Immunol. 2019;20:1291\u20138.","journal-title":"Nat Immunol"},{"key":"4738_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12977-018-0445-y","volume":"15","author":"A de la Torrents","year":"2018","unstructured":"de la Torrents A, Sanders RW. Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies. Retrovirology. 2018;15:63.","journal-title":"Retrovirology"},{"key":"4738_CR50","doi-asserted-by":"publisher","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","volume":"9","author":"RW Sanders","year":"2013","unstructured":"Sanders RW, Derking R, Cupo A, Julien J-P, Yasmeen A, de Val N, Kim HJ, Blattner C, de la Pe\u00f1a AT, Korzun J, et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies. PLoS Pathog. 2013;9:e1003618.","journal-title":"PLoS Pathog"},{"key":"4738_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature12966","volume":"507","author":"BE Correia","year":"2014","unstructured":"Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, et al. Proof of principle for epitope-focused vaccine design. Nature. 2014;507:201\u20136.","journal-title":"Nature"},{"key":"4738_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00792-005-0484-x","volume":"10","author":"J Tatur","year":"2006","unstructured":"Tatur J, Hagedoorn P-L, Overeijnder ML, Hagen WR. A highly thermostable ferritin from the hyperthermophilic archaeal anaerobe Pyrococcus furiosus. Extremophiles. 2006;10:139\u201348.","journal-title":"Extremophiles"},{"key":"4738_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","volume":"12","author":"K Sliepen","year":"2015","unstructured":"Sliepen K, Ozorowski G, Burger JA, van Montfort T, Stunnenberg M, LaBranche C, Montefiori DC, Moore JP, Ward AB, Sanders RW. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity. Retrovirology. 2015;12:82.","journal-title":"Retrovirology"},{"key":"4738_CR54","doi-asserted-by":"publisher","first-page":"e113463","DOI":"10.1371\/journal.pone.0113463","volume":"9","author":"SJ Krebs","year":"2014","unstructured":"Krebs SJ, McBurney SP, Kovarik DN, Waddell CD, Jaworski JP, Sutton WF, Gomes MM, Trovato M, Waagmeester G, Barnett SJ, et al. Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA. PLoS ONE. 2014;9:e113463.","journal-title":"PLoS ONE"},{"key":"4738_CR55","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","volume":"15","author":"D Fu","year":"2024","unstructured":"Fu D, Wang W, Zhang Y, Zhang F, Yang P, Yang C, Tian Y, Yao R, Jian J, Sun Z, et al. Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate. Nat Commun. 2024;15:8601.","journal-title":"Nat Commun"},{"key":"4738_CR56","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","volume":"20","author":"PM Folegatti","year":"2020","unstructured":"Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis. 2020;20:816\u201326.","journal-title":"Lancet Infect Dis"},{"key":"4738_CR57","doi-asserted-by":"publisher","first-page":"199156","DOI":"10.1016\/j.virusres.2023.199156","volume":"334","author":"W Tai","year":"2023","unstructured":"Tai W, Zheng J, Zhang X, Shi J, Wang G, Guan X, Zhu J, Perlman S, Du L. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. Virus Res. 2023;334:199156.","journal-title":"Virus Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04738-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04738-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:02:45Z","timestamp":1789383765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04738-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4738"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04738-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments were carried out following the guidelines of the Guangzhou National Laboratory institutional committee for the care and use of laboratory animals and were approved by the animal ethics committee of Guangzhou National Laboratory Animal Center (Approval Number: GZLAB-AUCP-2023-03-A05). All authentic SARS-CoV-2 (Wuhan-Hu-1) and MERS-CoV (ChinaGD01) experiments were conducted in ABSL-3 facility of Guangzhou National Laboratory and approved by the biosafety ethics committee of Guangzhou National Laboratory (Approval Number: GZLAB-AUCP-2025-06-A03).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"860"}}